Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Horgusluoglu et al., 2021
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male wistar Bonn/Kobori rats
doi:10.1073/pnas.77.10.5754
Similar content being viewed by others Subjects The approval of GLP-1R agonists for obesity and diabetes mellitus has resulted in higher demand and prescription for these indications, and a GLP-1R agonist is currently in a phase 3 clinical trial in metabolic dysfunction-associated steatohepatitis (MASH) 1
US$ 27.61
US$ 24.44
US$ 28.73
US$ 29.26
